CINECA IRIS Institutional Research Information System

Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe

D'Ascenzo, Fabrizio;Moretti, Claudio;Scarano, Silvia;Alfonso, Emilio;Gaita, F.
2016-01-01
2016
220
488
495
www.elsevier.com/locate/ijcard
Acute coronary syndrome; Clopidogrel; Ethnicity; P2Y12 receptor; Platelet inhibitor; Prasugrel; Ticagrelor; Acute Coronary Syndrome; Aged; Europe; Far East; Female; Follow-Up Studies; Hemorrhage; Humans; Internationality; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Registries; Retrospective Studies; Ticlopidine; Treatment Outcome; Cardiology and Cardiovascular Medicine
Giordana, Francesca*; Montefusco, Antonio; D'Ascenzo, Fabrizio; Moretti, Claudio; Scarano, Silvia; Abu-Assi, Emad; Raposeiras-Roubín, Sergio; Henrique...espandi
03A-Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1664655
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact